Uncategorized
Ocular Hypertension Pipeline Review, H1 2019 by Stage of Development, Drug Target, MoA, RoA and Molecule Type – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Ocular Hypertension - Pipeline Review, H1 2019" drug pipelines has been added to ResearchAndMarkets.com's offering. Ocular Hypertension - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Ocular Hypertension (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological actio